|
PM20D2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.215900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.807790E-01 |
| Normal-vs-Stage2 |
4.483600E-01 |
| Normal-vs-Stage3 |
3.161800E-03 |
| Normal-vs-Stage4 |
5.76239999999784E-05 |
| Stage1-vs-Stage2 |
9.907000E-01 |
| Stage1-vs-Stage3 |
4.187700E-02 |
| Stage1-vs-Stage4 |
3.884700E-03 |
| Stage2-vs-Stage3 |
1.939780E-01 |
| Stage2-vs-Stage4 |
4.760200E-02 |
| Stage3-vs-Stage4 |
3.496600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.398900E-03 |
| Normal-vs-AfricanAmerican |
5.759700E-02 |
| Normal-vs-Asian |
7.012800E-01 |
| Caucasian-vs-AfricanAmerican |
9.405400E-01 |
| Caucasian-vs-Asian |
3.648000E-01 |
| AfricanAmerican-vs-Asian |
2.960000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.036410E-02 |
| Normal-vs-Female |
1.356120E-02 |
| Male-vs-Female |
7.359600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.263800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.951500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.882090E-02 |
| Normal-vs-Age(81-100Yrs) |
5.204300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.966400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.662000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.696200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.547200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.203800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.929400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.519600E-01 |
| Normal-vs-Grade 2 |
9.622800E-01 |
| Normal-vs-Grade 3 |
3.605700E-04 |
| Normal-vs-Grade 4 |
1.03769992598757E-10 |
| Grade 1-vs-Grade 2 |
7.728600E-01 |
| Grade 1-vs-Grade 3 |
1.060810E-01 |
| Grade 1-vs-Grade 4 |
3.238200E-04 |
| Grade 2-vs-Grade 3 |
9.781400E-04 |
| Grade 2-vs-Grade 4 |
3.7684000364635E-10 |
| Grade 3-vs-Grade 4 |
2.441200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.183400E-01 |
| Normal-vs-ccB subtype |
5.56860000000547E-07 |
| ccA subtype-vs-ccB subtype |
5.72540004295519E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.869500E-02 |
| Normal-vs-N1 |
1.53824999999941E-05 |
| N0-vs-N1 |
2.503500E-02 |
|
|
